Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Feb 15, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Rxsight, Inc.
| 8K |
$50.83 | $406,672.80 | +36.63% | 29.84K |
Feb 12 - Feb 14
| |||||||
Rxsight, Inc.
| -937.40K |
$29.73 | -$14,695,695.32 | -97.57% | 23.39K |
Nov 28 - Nov 30
| |||||||
Rxsight, Inc.
| -500.00K |
$27.18 | -$13,590,750.00 | -50.29% | 494.31K |
Nov 14 - Nov 15
| |||||||
Lexeo Therapeutics, Inc.
| 2.57M |
$11.00 |
—
|
∞
| 2.57M |
Nov 7
| |||||||
Lexeo Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Rxsight, Inc.
| -32.95K |
$30.14 | -$992,968.65 | -61.97% | 20.22K |
Sep 7 - Sep 11
| |||||||
Rxsight, Inc.
| -282.12K |
$29.25 | -$474,129.38 | -36.10% | 499.43K |
Aug 24 - Aug 25
| |||||||
Rxsight, Inc.
| -33.13K |
$29.62 | -$981,570.47 | -32.63% | 68.41K |
Aug 17 - Aug 18
| |||||||
Rxsight, Inc.
| -464.20K |
—
|
—
| -29.76% | 1.1M |
Aug 9
| |||||||
Rxsight, Inc.
| -265.84K |
—
|
—
| -25.38% | 781.74K |
Jun 14
| |||||||
Rxsight, Inc.
| 5.73K |
—
|
—
| +9.27% | 67.57K |
Jun 1
| |||||||
Rxsight, Inc.
| -464.01K |
—
|
—
| -23.00% | 1.55M |
May 26
| |||||||
Rxsight, Inc.
| 480K |
$12.50 | $6,000,000.00 | +96.00% | 980K |
Feb 10
| |||||||
Vera Therapeutics, Inc.
| 1.71M |
$7.00 | $11,999,995.00 |
∞
| 1.71M |
Feb 6
| |||||||
Rxsight, Inc.
| 10.35K |
—
|
—
| +56.37% | 28.71K |
Jun 2
| |||||||
Sierra Oncology, Inc.
| -2.12M |
—
|
—
| -98.59% | 30.38K |
Apr 27
| |||||||
Inozyme Pharma, Inc.
| 1.35M |
$3.69 | $4,999,950.00 | +48.06% | 4.17M |
Apr 19
| |||||||
Vera Therapeutics, Inc.
| 333.33K |
$15.00 | $4,999,995.00 | +10.76% | 3.43M |
Feb 10
| |||||||
Sierra Oncology, Inc.
| 175K |
$27.00 | $4,725,000.00 |
∞
| 175K |
Feb 2
| |||||||
Sierra Oncology, Inc.
| 487.45K |
$13.20 | $6,434,353.20 | +33.00% | 1.96M |
Jan 25
| |||||||
Rxsight, Inc.
| 2.5M |
$16.00 | $10,200,000.00 | +42,688.39% | 2.51M |
Aug 3
| |||||||
Rxsight, Inc.
| 5.86K |
—
|
—
|
∞
| 5.86K |
Jul 30
| |||||||
Rxsight, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Rapid Micro Biosystems, Inc.
| 3.49M |
$20.00 | $3,000,000.00 | +5,466.78% | 3.56M |
Jul 19
| |||||||
Rapid Micro Biosystems, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Eargo, Inc.
| -994.99K |
—
|
—
| -34.03% | 1.93M |
May 17
| |||||||
Vera Therapeutics, Inc.
| 3.1M |
$11.00 |
—
|
∞
| 3.1M |
May 18
| |||||||
Vera Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Talaris Therapeutics, Inc.
| 3.22M |
$17.00 |
—
|
∞
| 3.22M |
May 11
| |||||||
Talaris Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Eargo, Inc.
| -994.99K |
—
|
—
| -25.39% | 2.92M |
Apr 14
|
Scheduled
| ||||||
89bio, Inc.
| -844.06K |
—
|
—
| -32.45% | 1.76M |
Nov 16
| |||||||
Eargo, Inc.
| 3.92M |
$18.00 |
—
|
∞
| 3.92M |
Oct 20
| |||||||
Eargo, Inc.
|
0
|
—
|
—
|
—
|
0
|
Oct 15
| |||||||
Eargo, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Axonics Modulation Technologies, Inc.
| -9.17K |
$42.67 | -$391,119.22 | -72.37% | 3.5K |
Sep 18
| |||||||
Molecular Templates, Inc.
| -3.50K |
$10.75 | -$37,568.37 | -100.00% |
0
|
Aug 28
| |||||||
Axonics Modulation Technologies, Inc.
| 3.5K |
—
|
—
| +38.18% | 12.67K |
Aug 24
| |||||||
Axonics Modulation Technologies, Inc.
| -2.39K |
$43.22 | -$103,422.11 | -20.70% | 9.17K |
Aug 14
| |||||||
Axonics Modulation Technologies, Inc.
| -974.58K |
—
|
—
| -33.12% | 1.97M |
Aug 10
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.